People in brief | ChromaDex, Pharmavite, Karo

People in brief | ChromaDex, Pharmavite, Karo

13 August 2019 - Deborah Wilkes

ChromaDex, Pharmavite and Karo Pharma have all recently announced senior management changes.

Andrew Shao joins ChromaDex

ChromaDex has announced a number of appointments including Andrew Shao as vice president of scientific and regulatory affairs.

Shao has previously worked for the US Council for Responsible Nutrition (CRN), Herbalife Nutrition and Amway's Nutrilite. He is a member of the editorial boards of several peer-review publications including The Journal of the International Society of Sports Nutrition, the Journal of Dietary Supplements and Advances in Nutrition.

He reports to Matthew Roberts, chief scientific officer of ChromaDex.

The US-based vitamins, minerals and supplements (VMS) specialist has also appointed Alberto Bottene as senior vice president of sales and business development. Bottene has previously worked for Guthy-Renker and Wella.

The company has also hired Megan Jordan as chief communications officer and senior vice president of global corporate affairs. She has previously worked for Herbalife Nutrition and Southern California Edison.

Jordan reports to chief executive officer Rob Fried.

Pharmavite promotes Donaldson

Pharmavite has promoted Bryan Donaldson to executive vice president of sales.

Donaldson was previously divisional vice-president of sales, with responsibility for the US-based company's relationship with retailer Costco at home and abroad. He joined Pharmavite in 2016.

Vitamins, minerals and supplements (VMS) specialist Pharmavite is a subsidiary of Japan's Otsuka Pharmaceutical Co.

Karo has new chief financial officer

Swedish specialty pharmaceutical company Karo Pharma has appointed Jon Johnsson as chief financial officer with effect from 1 October 2019.

Johnsson joins Karo from Atlas Copco where he is vice president finance for one of the company's divisions.

He replaces Mats-Olof Wallin who will retire towards the end of the year. Karo said Johnsson and Wallin would work together until the middle of December to ensure an orderly transition.

Private-equity firm EQT took a majority stake in Karo in January 2019. Soon afterwards, Christoffer Lorenzen was appointed chief executive officer following the resignation of Peter Blom (click here to read the News story).

Click tags below for more information on topics:

ChromaDex Council for Responsible Nutrition Pharmavite Karo Pharma

Back to Industry News

Share this page: